Quantcast

Latest RIDGEFIELD Stories

2015-03-16 08:31:21

-- Data show initial therapy in newly diagnosed NVAF patients diverged from guideline recommendations RIDGEFIELD, Conn., March 16, 2015 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals,

2015-03-02 08:34:18

-- First BLA submission for an investigational reversal agent for a novel oral anticoagulant RIDGEFIELD, Conn., March 2, 2015 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc.

2015-02-12 08:36:18

- Less than 1 in 3 patients and caregivers are prepared for how IPF will affect their daily life RIDGEFIELD, Conn., Feb.

2015-02-02 08:29:37

Only prescription medication in U.S. to combine the dual mechanisms of action of SGLT2 and DPP-4 inhibitors to improve glycemic control as an adjunct to diet and exercise RIDGEFIELD, Conn.

2015-01-21 08:29:43

New choice between mist and dry powder inhalers for tiotropium RIDGEFIELD, Conn., Jan. 21, 2015 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc.

2015-01-12 08:29:37

- Results from two large trials individually showed an improvement in the secondary endpoint of overall survival for patients with the most common EGFR mutation (Del19) RIDGEFIELD, Conn., Jan.

2014-12-30 23:06:28

Tell your story concisely, consistently, interestingly Ridgefield, Connecticut (PRWEB) December 30, 2014 To gain market position, start-ups and medium-sized

2014-12-08 16:25:45

- Phase I study results presented at American Society of Hematology Annual Meeting RIDGEFIELD, Conn., Dec. 8, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc.

2014-11-18 12:29:12

- Retrospective analysis of more than 38,000 patients shows PRADAXA is associated with lower rates of stroke and major bleeding compared to warfarin RIDGEFIELD, Conn., Nov.

2014-11-18 12:29:07

- Effects of idarucizumab on an exploratory marker of blood clotting, presented at the American Heart Association's Scientific Sessions RIDGEFIELD, Conn., Nov.


Word of the Day
bowerly
  • Large; stout; burly.
The word 'bowerly' is an alteration of 'burly'.